Patel Dhavalkumar Dhirajlalinsider trades

In SEC Form 4 filings, Patel Dhavalkumar Dhirajlal is listed as EVP, Chief Scientific Officer of Sana Biotechnology, Inc. (SANA). Patel Dhavalkumar Dhirajlal reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Aug 27.

Companies and roles

Company	Role	Transactions	Last filed
SANASana Biotechnology, Inc.	EVP, Chief Scientific Officer	3	Aug 27

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-27

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
SANASana Biotechnology, Inc.	Aug 27	Aug 27	F	41,158	$4.11	$169,159	183,352	No	Form 4
SANASana Biotechnology, Inc.	Aug 26	Aug 27	M	125,000	$0.00	$0	224,510	No	Form 4
SANASana Biotechnology, Inc.	Aug 26	Aug 27	M · derivative	125,000	$0.00	$0	250,000	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.